Refine by
Genetic Disease Suppliers & Manufacturers
63 companies found
based inChangsha, CHINA
Sansure Biotech Inc. is an in vitro diagnostic solution provider integrating diagnostic reagents, instruments and independent clinic laboratory services with its own innovative gene technology as its core. The company is committed to becoming a ...
based inWayne, PENNSYLVANIA (USA)
Palvella Therapeutics was founded to serve individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. We focus on developing therapies that specifically target the root ...
QTORIN™ rapamycin 3.9%is a novel targeted topical therapy being studied for Gorlin syndrome. Palvella is enrolling a phase 2b clinical study (CODY) for people with Gorlin ...
based inWoodside, CALIFORNIA (USA)
The Manzanita tree is part of the California chaparral, a genre of native plants that survives brushfires and can thrive even in difficult environments. Manzanita Pharmaceuticals, Inc. was founded in May 2007 with data supported by DARPA in a prior ...
Nervelight™, a topical, intraoperative nerve imaging agent that is selective for at-risk nerve tissue in cancer ...
based inDublin, IRELAND
Medical Supply Company is one of Ireland’s leading suppliers of Reagents, Equipment and IT for the Clinical Diagnostics, Life Sciences, Pharma and Health Informatics sectors. Medical Supply Company was established in 1971 and is an Irish owned ...
based inGrove City, OHIO (USA)
Forge is developing innovative gene therapies that aim to help patients suffering from devastating rare diseases. Forge is building capacity to directly address the growing demand for gene therapy manufacturing. Forge is currently building the ...
based inSchwerte, GERMANY
Fleischhacker GmbH & Co. KG, headquartered in Schwerte, is a trading company for medical and laboratory technology with many years of experience in the international aid business. In Germany, we mainly supply hospitals, general practitioners, ...
Medical research is being increasingly conducted in networks of ever-larger research alliances. In order to make this possible, MediConnect Research®, in combination with MediConnect®, provides the necessary structured data ...
based inHeidelberg, GERMANY
Molecular Health is an international biotech IT company based in Heidelberg, Germany, that has been developing innovative software in the areas of in silico and precision medicine since 2004. Molecular Health’s solutions make it possible to ...
Use worldwide knowledge to reliably determine the risk of genetic disease. MH Guide/Mendel is optimized for the evaluation of germline variants associated with hereditary diseases. The software ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
In alignment with our commitment to scientific innovation and areas of unmet medical need, we may provide product and funding support for independent research in rare diseases and genetic ...
based inBoston, MASSACHUSETTS (USA)
Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to ...
These enzymes are meticulously crafted using proprietary algorithms powered by state-of-the-art GPT neural networks, which are capable of redesigning nucleases for specific genetic targets. This approach allows Neoclease to tailor ...
based inMelville, NEW YORK (USA)
Population Bio, Inc. is a privately held precision medicine company that is empowering pharmaceutical companies to develop targeted therapies and companion diagnostics faster and more cost effectively. We are accelerating the delivery of precision ...
Population Bio’s patented CNV Beacon® platform is a rapid genetic discovery method that focuses first on identifying disease-relevant copy number variants (CNVs). Once a gene or genomic region is ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inSeoul, SOUTH KOREA
NGS industries are rapidly evolving and our customers are in greater need of technical support in various research fields and markets. Just like a chameleon utilizing its colored pigments and crystals to adapt to its surroundings, we proactively ...
Celemics’ G-Mendeliome Clinical Exome Sequencing (CES) Panel is designed to overcome the limitations of analyzing clinical diseases with conventional whole-exome ...
based inToronto, ONTARIO (CANADA)
Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI. Programming RNA Therapies Any Gene, Any Genetic Condition. Revolutions in AI, RNA biology and automation ...
AI Drives Unprecedented Number of Valuable Medicines by Combining Prediction and Scale. Our proprietary AI Workbench is designed for data-driven prediction, positive feedback loops, and exponential growth. It enables us to identify leads for over ...
based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
based inCambridge, MASSACHUSETTS (USA)
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with ...
CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a ...
based inGuangzhou, CHINA
Four E's Scientific, part of the FOUR E's Industrial Group established in 2009, is focused on providing Laboratories worldwide with high-quality instruments & supplies, thereby furthering Scientific Research. Today, we are one of the fastest growing ...
960406 Real-time PCR is a 96 well quantitative fluorescence Real-time PCR System, equipped with a 10.1-inch high-definition color touch screen and built-in analysis software for intuitive operation and analysis. Combining the innovative thermal ...
based inDessau-Rosslau, GERMANY
IDT Biologika is an international leader in the contract development and manufacture of Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, Oncolytic Viruses, Virus-Like Particles, and other biologics. We are a full-service biologics ...
IDT Biologika is a leading viral vector CDMO with an exceptional track record in biologics manufacturing, including expertise with live viral agents. This makes us well-positioned to support the rapid growth in gene therapy and immunotherapeutics ...
based inWuhan, CHINA
Wuhan Healthcare Biotechnology Co., Ltd. (Healthcare) is specialized in the production of high quality in vitro diagnostic reagents and instrumentation products that empower clinicians to treat patients faster than before and intended for hospitals, ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
based inBalerna, SWITZERLAND
PRIMA Lab SA, modern Swiss Company in the diagnostic field, develops the core of its innovation offering simple and efficient devices CE certified, for a quick check-up of human and animal’s health conditions. Thanks to its complete range of tests, ...
Self-test for the detection of anti deamidated gliadin (anti-DGP) antibodies, IgA and IgG, in blood, for celiac disease ...
